Stock analysts at Robert W. Baird initiated coverage on shares of Vaxxinity (NASDAQ:VAXX – Get Free Report) in a research report issued to clients and investors on Thursday, FlyOnTheWall reports. The brokerage set an “outperform” rating and a $7.00 price target on the stock. Robert W. Baird’s price objective points to a potential upside of […]